David J. Sundin

431 total citations
13 papers, 262 citations indexed

About

David J. Sundin is a scholar working on Genetics, Otorhinolaryngology and Biochemistry. According to data from OpenAlex, David J. Sundin has authored 13 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Otorhinolaryngology and 3 papers in Biochemistry. Recurrent topics in David J. Sundin's work include Ear Surgery and Otitis Media (4 papers), Blood transfusion and management (3 papers) and Peptidase Inhibition and Analysis (2 papers). David J. Sundin is often cited by papers focused on Ear Surgery and Otitis Media (4 papers), Blood transfusion and management (3 papers) and Peptidase Inhibition and Analysis (2 papers). David J. Sundin collaborates with scholars based in United States, France and Belgium. David J. Sundin's co-authors include Lily Lin, Laurence Corash, Michèle Jacquet, Daniel Kientz, Jean‐Pierre Cazenave, Philip J. Barr, Philip A. Pemberton, P L Simon, Hervé Isola and Karen M. Kim and has published in prestigious journals such as Blood, The Laryngoscope and Transfusion.

In The Last Decade

David J. Sundin

13 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Sundin United States	8	85	70	52	47	40	13	262
Barbara Hannach Canada	11	182 2.1×	70 1.0×	33 0.6×	17 0.4×	124 3.1×	17	331
Lisa J. Cardo United States	11	118 1.4×	53 0.8×	13 0.3×	33 0.7×	69 1.7×	16	450
Y. Piquet France	11	27 0.3×	35 0.5×	112 2.2×	38 0.8×	72 1.8×	22	371
E. Strobel Germany	7	49 0.6×	22 0.3×	33 0.6×	9 0.2×	168 4.2×	33	273
N. A. Anderson United Kingdom	7	70 0.8×	35 0.5×	29 0.6×	17 0.4×	141 3.5×	11	392
Marcus B. Simpson United States	11	109 1.3×	39 0.6×	45 0.9×	19 0.4×	151 3.8×	22	335
So‐Yong Kwon South Korea	6	38 0.4×	34 0.5×	32 0.6×	23 0.5×	56 1.4×	26	284
F. Meyer France	8	50 0.6×	18 0.3×	40 0.8×	14 0.3×	376 9.4×	27	468
Cathy Schechterly United States	9	30 0.4×	13 0.2×	82 1.6×	10 0.2×	41 1.0×	12	350
Yong Gon Cho South Korea	11	30 0.4×	11 0.2×	36 0.7×	44 0.9×	72 1.8×	50	284

Countries citing papers authored by David J. Sundin

Since Specialization

Citations

This map shows the geographic impact of David J. Sundin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Sundin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Sundin more than expected).

Fields of papers citing papers by David J. Sundin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Sundin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Sundin. The network helps show where David J. Sundin may publish in the future.

Co-authorship network of co-authors of David J. Sundin

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Sundin. A scholar is included among the top collaborators of David J. Sundin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Sundin. David J. Sundin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Schlenke, Peter, Johannes Irsch, David J. Sundin, et al.. (2011). Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients. Annals of Hematology. 90(12). 1457–1465. 14 indexed citations

Cazenave, Jean‐Pierre, Daniel Kientz, Isabelle Mendel, et al.. (2010). An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment. Transfusion. 50(6). 1210–1219. 39 indexed citations

Simon, P L, Hervé Isola, Daniel Kientz, et al.. (2009). Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion. Transfusion. 49(6). 1083–1091. 90 indexed citations

Cazenave, Jean‐Pierre, et al.. (2008). An active hemovigilance program utilizing an EDC system to assess safety of 2994 plasma transfusions prepared with the INTERCEPT Blood System (TM). Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 48(2). 3 indexed citations

Cazenave, Jean‐Pierre, M. Lambermont, Olivier Garraud, et al.. (2007). An Active Hemovigilance Program Characterizing the Safety Profile of 7,437 Platelet Transfusions Prepared with Photochemical Treatment (INTERCEPT™).. Blood. 110(11). 2894–2894. 1 indexed citations

Antonelli, Patrick J., et al.. (2005). Inflammatory Proteases in Chronic Otitis Externa. The Laryngoscope. 115(4). 651–654. 4 indexed citations

Pemberton, Philip A., Karen M. Kim, David J. Sundin, et al.. (2005). An Inhaled Matrix Metalloprotease Inhibitor Prevents Cigarette Smoke-Induced Emphysema in the Mouse. COPD Journal of Chronic Obstructive Pulmonary Disease. 2(3). 303–310. 31 indexed citations

Antonelli, Patrick J., Gregory S. Schultz, David J. Sundin, Philip A. Pemberton, & Philip J. Barr. (2004). Alpha‐1‐Antitrypsin Single Dose Adjuvant Therapy for Acute Otitis Media. Otolaryngology. 131(2). 1 indexed citations

Antonelli, Patrick J., Gregory S. Schultz, David J. Sundin, Philip A. Pemberton, & Philip J. Barr. (2003). Protease inhibitors α₁‐antitrypsin and ilomastat are not ototoxic in the chinchilla. The Laryngoscope. 113(10). 1764–1769. 10 indexed citations

10.

Antonelli, Patrick J., Gregory S. Schultz, Karen M. Kim, et al.. (2003). Alpha 1‐Antitrypsin and Ilomastat Inhibit Inflammatory Proteases Present in Human Middle Ear Effusions. The Laryngoscope. 113(8). 1347–1351. 16 indexed citations

11.

Lalezari, Jacob, Peter Ruane, Calvin Cohen, et al.. (2000). Low-Dose Daily Subcutaneous Interleukin-2 in Combination with Highly Active Antiretroviral Therapy in HIV + Patients: A Randomized Controlled Trial. HIV Clinical Trials. 1(3). 1–15. 35 indexed citations

12.

Sundin, David J., et al.. (1998). Aldesleukin therapy in HIV-infected patients. American Journal of Health-System Pharmacy. 55(14). 1520–1523. 5 indexed citations

13.

Sundin, David J., et al.. (1998). Toxicity Management in Patients Receiving Low-Dose Aldesleukin Therapy. Annals of Pharmacotherapy. 32(12). 1344–1352. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact